Home  >  Products  >  ADRA1B (adrenergic, alpha-1B-, receptor) Blocking Peptide (the N terminal of ADRA1B)(100ug)
ADRA1B (adrenergic, alpha-1B-, receptor) Blocking Peptide (the N terminal of ADRA1B)(100ug)

ADRA1B (adrenergic, alpha-1B-, receptor) Blocking Peptide (the N terminal of ADRA1B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ADRA1B Antibody (ARP59961_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59961
Size: 100ug
Weight: 57kDa
Gene: 147
Format: Lyophilized powder
Target: Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1B-adrenergic receptor, which induces neoplastic transformation when transfected into NIH 3T3 fibroblasts and other cell lines. Thus, this normal cellular gene is identified as a protooncogene
Alternative names: ADRA1; ALPHA1BAR
See Full Product Listings >